Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ-0,58
KB0,48
PKN71,4771,5-1,79
Msft-1,22
Nokia4,5754,7751,01
IBM-2,28
Mercedes-Benz Group AG53,1653,17-0,04
PFE-2,04
21.05.2025 22:30:00
Indexy online
AD Index online
select
AD Index online
 

  • 25.03.2025 8:52:30
MediClin AG (MEDG.F, Frankfurt)
Poslední obchod Změna (%) Změna (EUR) Objem obchodů (EUR)
2,94 1,41 0,04 882
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 21.05.2025
Popis společnosti
Obecné informace
Název společnostiMediClin AG
TickerMED
Kmenové akcie:Ordinary Shares
RICMEDG.DE
ISINDE0006595101
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky31.03.2025
Počet zaměstnanců k 31.03.2025 6 912
Akcie v oběhu k 31.03.2025 47 500 000
MěnaEUR
Kontaktní informace
UliceOkenstr. 27
MěstoOFFENBURG
PSČ77652
ZeměGermany
Kontatní osobaEnder Gulcan
Funkce kontaktní osobyHead of Investor Relations and Sustainability
Telefon 497 814 880
Fax49781488133
Kontatní telefon49 781 488 184

Business Summary: MediClin AG is a Germany-based company. The Company is engaged in providing professional medical servies in the fields of acute care (acute segment) and rehabilitation (post-acute segment), as well as nursing care services, through its hospitals. It focuses on a range of services in the acture and post-acute segments, such as: neurology, neurological early rehabilitation, neurosurgery, psychosomatics and psychiatry, geriatrics, as well as orthopaedics. Other areas of special competencies are: tinnitus, cochlea implants and internal medicine (cardiology, pneumology, edocrinology), as well as the treatment of post- and long-COVID-19 symptoms.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2024, MediClin AG revenues decreased less than 1% to EUR765.1M. Net income totaled EUR24.8M vs. loss of EUR10.8M. Revenues reflect Sales increase of 3% to EUR748.8M, also reflect Utilization of Licensed Beds - Post-A. decrease of 10% to 89%, Other Operating Income decrease of 55% to EUR16.3M. Net income reflects Acute segment loss decrease of 98% to EUR600K. Dividend per share totaled to EUR0.04.
Odvětvová klasifikace
TRBC2009Healthcare Facilities / Services
TRBC2012Hospitals, Clinics & Primary Care Services
RBSS2004Healthcare Facilities
MGINDUSTRYHealthcare Facilities
MGSECTORHealthcare
NAICSGeneral Medical and Surgical Hospitals
NAICSSpecialty (except Psychiatric and Substance Abuse) Hospitals
NAICS2007General Medical and Surgical Hospitals
NAICS2007Specialty (except Psychiatric and Substance Abuse) Hospitals
NAICS1997General Medical and Surgical Hospitals
NAICS1997Specialty (except Psychiatric and Substance Abuse) Hospitals
SICGeneral Med'L/surgical Hospitals
SICSpecialty Hospitals Not Psych'Ric



  • Poslední aktualizace: 21.05.2025
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Supervisory BoardJan Liersch5222.11.201922.11.2019
Chairman of the Management Board, Chief Executive OfficerJoachim Ramming5301.08.202101.08.2021
Vice Chairman of the Supervisory Board, Employee RepresentativeHans Hilpert5913.03.200213.03.2002
Chief Financial Officer, Member of the Management BoardTino Fritz4901.09.201820.02.2018
Chief Operating Officer, Member of the Management BoardThomas Piefke5701.10.202301.10.2023